Results of Annual General Meeting
June 1, 2018
In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), Imagion Biosystems Limited (ASX: IBX) (the Company) advises the results
Category: Investor updates
Investor Presentation — 2017 Annual General Meeting
June 1, 2018
The investor presentation “MagSense® Technology: A New Diagnostic for Targeted Early Detection of Cancer” was presented at the 2017 Annual General Meeting. View the Investor
Chairman's Address to Shareholders — 2017 Annual General Meeting
June 1, 2018
From Chairman Bob Proulx’s Address to Shareholders at the 2018 Annual General Meeting, held 31 May, 2018: “We all know that far to many people’s
Amendment to Notice of Annual General Meeting
May 23, 2018
Further to Imagion Biosystems Limited’s announcement dated 23 May 2018, the Company advises of an amendment to Resolution 9 of its Notice of Annual General
Imagion Biosystems Announces MD Anderson Cancer Center Takes Equity Stake
May 23, 2018
Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce that the Company’s principal collaborator,
Appendix 3X — Final Director's Interest Notice
May 4, 2018
Imagion Biosystems Limited has lodged Appendix 3X, Final Director’s Interest Notice, with the Australian Securities Exchange. View the Final Director’s Interest Notice.
Appendix 3X — Initial Director's Interest Notice
May 4, 2018
Imagion Biosystems Limited has lodged Appendix 3X, Initial Director’s Interest Notice, with the Australian Securities Exchange. View the Initial Director’s Interest Notice.
Notice of Annual General Meeting/Proxy Form
May 3, 2018
Imagion Biosystems Limited has lodged the ASX Announcement, Notice of Annual General Meeting/Proxy Form. View the Notice of Annual General Meeting/Proxy Form.
Appendix 4C — Quarterly
April 28, 2018
Imagion Biosystems Limited has announced Appendix 4C, Quarterly report for entities subject to Listing Rule 4.7B, for the quarter ended 31 March, 2018. Read Appendix 4C,
Director Appointment/Resignation
April 27, 2018
Imagion Biosystems Announces New Director Experienced life sciences executive Ms Bronwyn Le Grice appointed Director Retirement ot Mr Peter Di Chiara as Director MELBOURNE —